Angiotensin II receptor type 1 mRNA is unregulated in atria of patients with end stage heart failure

被引:13
|
作者
Kaprielian, RR [1 ]
Dupont, E [1 ]
Hafizi, S [1 ]
PooleWilson, PA [1 ]
Khaghani, A [1 ]
Yacoub, MH [1 ]
Sever, NJ [1 ]
机构
[1] HAREFIELD HOSP, HEART SCI CTR, HAREFIELD UB9 6BP, MIDDX, ENGLAND
关键词
heart failure; angiotensin II receptor; myocardium;
D O I
10.1006/jmcc.1997.0458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is increasing evidence that pathological changes in the myocardium during chronic heart failure (CHF) are partly regulated through the activation of the renin-angiotensin system (RAS), an effect mediated by the angiotensin II type 1 receptor (AT(1)R), We examined the expression of cardiac AT(1)R mRNA in normal (atria, n=7: ventricle, n=3) and end-stage CHF human hearts (atria, n=8: ventricle, n=14). Tissue was snap-frozen immediately after explantation during orthotopic cardiac transplantation; control specimens were obtained from healthy donor hearts rejected for technical reasons. Northern blots of purified total mRNA from each tissue were hybridized with a random primed radiolabeled probe for the coding sequence of AT(1)R. Stringent conditions were used for both hybridization (5X SSC, 65 degrees C) and washing (0.5X SSC, 0.1% SDS, 65 degrees C) of the membrane, Left and right atrial tissue showed low levels of AT(1)R mRNA expression in the controls, with statistically significant upregulation of expression in tissue from pathological hearts; CHF atria 1.28+/-0.86 optical density (OD) units, control atria 0.56+/-0.31 OD units, P=0.05 (mean+/-S.D.). There were undetectable levels in ventricles from either control (2/2) or dilated hearts (7/7), The results were independent of the etiology of the heart failure and suggest that increased levels of atrial AT(1)R mRNA may occur in response to elevated atrial pressures in heart failure. (C) 1997 Academic Press Limited.
引用
收藏
页码:2299 / 2304
页数:6
相关论文
共 50 条
  • [1] Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure
    Matsumoto, T
    Ozono, R
    Oshima, T
    Matsuura, H
    Sueda, T
    Kajiyama, G
    Kambe, M
    CARDIOVASCULAR RESEARCH, 2000, 46 (01) : 73 - 81
  • [2] Angiotensin Type 1 Receptor Blockers in Heart Failure
    Singh, Khuraijam Dhanachandra
    Karnik, Sadashiva S.
    CURRENT DRUG TARGETS, 2020, 21 (02) : 125 - 131
  • [3] Gene polymorfism of angiotensin-converting enzyme and angiotensin II type 1 receptor in heart failure patients with atrial fibrillation
    Adela, Sitar-Taut
    Dana, Pop
    Dumitru, Zdrenghea
    Maria, Procopciuc Lucia
    Radu, Rosu
    Adela, Popa
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2010, 18 (02): : 35 - 42
  • [4] Downregulation of angiotensin II receptor type 1 in heart failure - A process of adaptation or deterioration?
    Kurabayashi, M
    Yazaki, Y
    CIRCULATION, 1997, 95 (05) : 1104 - 1107
  • [5] Regulation of angiotensin-(1–7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure
    Wen-na Zong
    Xiao-hui Yang
    Xiu-mei Chen
    Hong-juan Huang
    Hong-jian Zheng
    Xiao-yi Qin
    Yong-hong Yong
    Kejiang Cao
    Jun Huang
    Xin-zheng Lu
    Acta Pharmacologica Sinica, 2011, 32 : 1345 - 1350
  • [6] Regulation of angiotensin-(1-7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure
    Zong, Wen-na
    Yang, Xiao-hui
    Chen, Xiu-mei
    Huang, Hong-juan
    Zheng, Hong-jian
    Qin, Xiao-yi
    Yong, Yong-hong
    Cao, Ke-jiang
    Huang, Jun
    Lu, Xin-zheng
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (11) : 1345 - 1350
  • [7] Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure
    Goodfield, NER
    Newby, DE
    Ludlam, CA
    Flapan, AD
    CIRCULATION, 1999, 99 (23) : 2983 - 2985
  • [8] Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure
    Chen, PM
    Leng, XG
    Fan, LL
    Ma, J
    Wang, YF
    Chen, LY
    CHINESE MEDICAL JOURNAL, 2005, 118 (22) : 1886 - 1892
  • [9] Myocardial Angiotensin Metabolism in End-Stage Heart Failure
    Pavo, Noemi
    Prausmueller, Suriya
    Spinka, Georg
    Goliasch, Georg
    Bartko, Philipp E.
    Wurm, Raphael
    Arfsten, Henrike
    Strunk, Guido
    Poglitsch, Marko
    Domenig, Oliver
    Mascherbauer, Julia
    Uyanik-Unal, Keziban
    Hengstenberg, Christian
    Zuckermann, Andreas
    Huelsmann, Martin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (14) : 1731 - 1743
  • [10] Angiotensin II receptor antagonists, elite drugs (or not) for patients with heart failure or hypertension?
    DG Beevers
    GYH Lip
    Journal of Human Hypertension, 1997, 11 : 329 - 330